Novel pharmacological therapy in inflammatory bowel diseases: beyond anti-tumor necrosis factor

C Pagnini, TT Pizarro, F Cominelli - Frontiers in Pharmacology, 2019 - frontiersin.org
Inflammatory bowel diseases (IBDs) are chronic conditions of the gastrointestinal tract in
which dysregulated immune responses cause persistent inflammation of the gut mucosa …

The role of Nrf2 in the pathogenesis and treatment of ulcerative colitis

S Peng, L Shen, X Yu, L Zhang, K Xu, Y Xia… - Frontiers in …, 2023 - frontiersin.org
Ulcerative colitis (UC) is a chronic inflammatory bowel disease involving mainly the
colorectal mucosa and submucosa, the incidence of which has been on the rise in recent …

Pathophysiology of inflammatory bowel disease: innate immune system

A Saez, B Herrero-Fernandez, R Gomez-Bris… - International journal of …, 2023 - mdpi.com
Inflammatory bowel disease (IBD), comprising Crohn's disease (CD) and ulcerative colitis
(UC), is a heterogeneous state of chronic intestinal inflammation with no exact known cause …

A role for transcription factor NF-kB in intestinal inflammation

AJG Schottelius, AS Baldwin Jr - International journal of colorectal disease, 1999 - Springer
Nuclear factor (NF) κ B is a transcription factor that controls the transcription of a variety of
cellular genes regulating the inflammatory response. Many proinflammatory cytokines are …

Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling

PJ Koelink, FM Bloemendaal, B Li, L Westera… - Gut, 2020 - gut.bmj.com
Objective Macrophage interleukin (IL)-10 signalling plays a critical role in the maintenance
of a regulatory phenotype that prevents the development of IBD. We have previously found …

TNF-α-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells

I Treede, A Braun, P Jeliaskova, T Giese… - BMC …, 2009 - Springer
Background Phosphatidylcholine (PC) is a major lipid of the gastrointestinal mucus layer.
We recently showed that mucus from patients suffering from ulcerative colitis has low levels …

Tumor necrosis factor: biology and therapeutic inhibitors

KA Papadakis, SR Targan - Gastroenterology, 2000 - Elsevier
Tumor necrosis factor (TNF) was originally described as a protein factor capable of killing
tumor cells in vitro and causing hemorrhagic necrosis of transplantable tumors in mice. 1, 2 …

[HTML][HTML] Nuclear factor kappa B role in inflammation associated gastrointestinal malignancies

S Gambhir, D Vyas, M Hollis, A Aekka… - World journal of …, 2015 - ncbi.nlm.nih.gov
Nuclear factor kappa B (NF-κB) has an established role in the regulation of innate immunity
and inflammation. NF-κB is also involved in critical mechanisms connecting inflammation …

NF-κB and disease

P Poma - International journal of molecular sciences, 2020 - mdpi.com
The role of NF-κB in all diseases characterized by an inflammatory process, from cancer to
autoimmune diseases, is known, but—precisely because it is involved in many diseases …

Tumour necrosis factor and Crohn's disease.

SJ Van Deventer - Gut, 1997 - ncbi.nlm.nih.gov
The production of several pro-inflammatory cytokines is increased in inflammatory bowel
diseases (IBD). Experimental models of IBD have further defined the importance of specific …